HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lily Hechtman Selected Research

Combined Modality Therapy

1/2022Review: Adult Outcome as Seen Through Controlled Prospective Follow-up Studies of Children With Attention-Deficit/Hyperactivity Disorder Followed Into Adulthood.
12/2020Childhood ADHD and Involvement in Early Pregnancy: Mechanisms of Risk.
11/2020Maternal personality traits moderate treatment response in the Multimodal Treatment Study of attention-deficit/hyperactivity disorder.
1/2020Effects of Childhood and Adult Persistent Attention-Deficit/Hyperactivity Disorder on Risk of Motor Vehicle Crashes: Results From the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder.
1/2020Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.
4/2019Predictive utility of childhood diagnosis of ICD-10 hyperkinetic disorder: adult outcomes in the MTA and effect of comorbidity.
1/2019Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD.
11/2018Maternal ADHD Symptoms, Personality, and Parenting Stress: Differences Between Mothers of Children With ADHD and Mothers of Comparison Children.
1/2018Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study.
1/2018How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lily Hechtman Research Topics

Disease

70Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2022 - 05/2002
7Substance-Related Disorders (Drug Abuse)
01/2018 - 09/2003
5Learning Disabilities (Learning Disability)
07/2004 - 07/2004
3Oppositional Defiant Disorder
03/2011 - 01/2003
2Confusion (Bewilderment)
07/2008 - 07/2008
1Anxiety Disorders (Anxiety Disorder)
01/2022
1Bulimia Nervosa
04/2010
1Nausea
02/2007
1Headache (Headaches)
02/2007
1Anorexia
02/2007
1Sleep Initiation and Maintenance Disorders (Insomnia)
02/2007

Drug/Important Bio-Agent (IBA)

36Pemetrexed (MTA)FDA Link
01/2022 - 05/2002
12Methylphenidate (Ritalin)FDA LinkGeneric
09/2012 - 01/2003
3Dextroamphetamine (Dexedrine)FDA LinkGeneric
05/2014 - 04/2006
2CatecholaminesIBA
01/2020 - 01/2017
2Dopamine (Intropin)FDA LinkGeneric
01/2017 - 05/2014
2Amphetamine (Amfetamine)FDA LinkGeneric
05/2014 - 09/2012
2Pharmaceutical PreparationsIBA
09/2012 - 08/2005
2Paroxetine (Paxil)FDA LinkGeneric
03/2011 - 04/2006
1Flavin-Adenine Dinucleotide (FAD)IBA
01/2022
1Biological ProductsIBA
11/2018
1Illicit Drugs (Recreational Drugs)IBA
01/2018
1trans-sodium crocetinate (crocetin)IBA
12/2015
1RacloprideIBA
05/2014
1LactoseFDA LinkGeneric
05/2014
1BuffersIBA
08/2012
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
10/2007
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2006
1Aligeron (AS 2)IBA
01/2003

Therapy/Procedure

52Combined Modality Therapy
01/2022 - 05/2002
6Therapeutics
01/2020 - 07/2004
2Aftercare (After-Treatment)
08/2012 - 05/2009
1Drug Therapy (Chemotherapy)
01/2020
1Ambulatory Care (Outpatient Care)
02/2007